Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124508673 | 12450867 | 3 | F | 20160412 | 20160711 | 20160609 | 20160722 | EXP | US-ACORDA-ACO_124624_2016 | ACORDA | 70.60 | YR | F | Y | 65.76000 | KG | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124508673 | 12450867 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | 240 | MG | Y | 22250 | 10 | MG | TABLET | Q12H | |||
| 124508673 | 12450867 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 240 | MG | Y | TCNN | 22250 | 10 | MG | TABLET | BID | ||
| 124508673 | 12450867 | 3 | SS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 40 MG, 3X/WK | U | U | 0 | 40 | MG | TIW | |||||
| 124508673 | 12450867 | 4 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, BID | U | 0 | 10 | MG | BID | ||||||
| 124508673 | 12450867 | 5 | C | REMERON | MIRTAZAPINE | 1 | Oral | 7.5 MG, HS | U | 0 | 7.5 | MG | QD | ||||||
| 124508673 | 12450867 | 6 | C | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 124508673 | 12450867 | 7 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 75 ?G, QD | U | 0 | 75 | UG | QD | ||||||
| 124508673 | 12450867 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | QD | ||||||
| 124508673 | 12450867 | 9 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 400 MG, BID | U | 0 | 400 | MG | BID | ||||||
| 124508673 | 12450867 | 10 | C | Fish oil | FISH OIL | 1 | Unknown | UNK, BID | U | 0 | BID | ||||||||
| 124508673 | 12450867 | 11 | C | Mvi | VITAMINS | 1 | Oral | UNK, QD | U | 0 | QD | ||||||||
| 124508673 | 12450867 | 12 | C | Probiotica | PROBIOTICS NOS | 1 | Unknown | UNK, QD | U | 0 | QD | ||||||||
| 124508673 | 12450867 | 13 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK, Q OTHER MONTH | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124508673 | 12450867 | 1 | Multiple sclerosis |
| 124508673 | 12450867 | 3 | Multiple sclerosis |
| 124508673 | 12450867 | 4 | Multiple sclerosis |
| 124508673 | 12450867 | 5 | Sleep disorder |
| 124508673 | 12450867 | 6 | Plasma cell myeloma |
| 124508673 | 12450867 | 7 | Hypothyroidism |
| 124508673 | 12450867 | 8 | Product used for unknown indication |
| 124508673 | 12450867 | 9 | Product used for unknown indication |
| 124508673 | 12450867 | 10 | Product used for unknown indication |
| 124508673 | 12450867 | 11 | Product used for unknown indication |
| 124508673 | 12450867 | 12 | Product used for unknown indication |
| 124508673 | 12450867 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124508673 | 12450867 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124508673 | 12450867 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124508673 | 12450867 | 1 | 20160407 | 20160412 | 0 | |
| 124508673 | 12450867 | 2 | 20160407 | 20160412 | 0 | |
| 124508673 | 12450867 | 3 | 20160322 | 0 |